Breast Reconstruction Rates Stable After Increase From 2005 to 2012
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study published online in the December issue of Plastic and Reconstructive Surgery.
Robyn N. Rubenstein, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined longitudinal trends in BR rates in the United States using data for mastectomy cases with and without BR from 2005 through 2017 abstracted from the National Surgical Quality Improvement Program database; the Surveillance, Epidemiology, and End Results Program database; and the National Cancer Database (NCDB). Predictors of reconstruction were identified, and race and insurance distributions were assessed over time.
The researchers found that 32.7 percent of 1,554,381 mastectomy patients underwent BR. From 2005 to 2012, there was an increase in the annual reconstruction rates per 1,000 mastectomies (incidence rate ratios, 1.077 for the National Surgical Quality Improvement Program; 1.090 for the Surveillance, Epidemiology, and End Results Program; and 1.092 for the NCDB); from 2013 to 2017, rates stabilized. The likelihood of undergoing BR was increased for patients who were younger (aged ≤59 years), privately insured, with fewer comorbidities, and who underwent contralateral prophylactic mastectomy. The increase in BR rates was higher among Black and Asian patients than White patients over time (252.3, 366.4, and 137.3 percent, respectively). BR rates increased more among Medicaid and Medicare patients compared with privately insured patients (418.6, 302.8, and 125.3 percent, respectively).
"We have demonstrated a stabilization in breast reconstruction rates over the past decade despite legislation to increase public awareness of access to breast reconstruction," the authors write. "Simultaneously, we observed a reduction in some historical health care disparities, including race and insurance type."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Abbreviated Breast MRI Has High Diagnostic Accuracy for Dense Breasts
THURSDAY, May 22, 2025 -- For women with extremely dense breasts who are negative for cancer at mammography, abbreviated breast magnetic resonance imaging (MRI) for first-round...
Pediatric Magnet Ingestion Rates Still High
THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...
Similar Survival Seen With Simple Versus Radical Hysterectomy for Cervical Cancer
WEDNESDAY, May 21, 2025 -- For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.